Contributions of efflux pumps to high level resistance of Pseudomonas aeruginosa to ciprofloxacin

Chinese Medical Journal

Volumn 120, Issue 1, 2007, Pages 68-70

  Wang, Dan Dan ^a   Sun, Tie Ying ^b   Hu, Yun Jian ^b  

^a GRADUATE SCHOOL OF PEKING UNION MEDICAL COLLEGE   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Ciprofloxacin; Drug resistance; Efflux pumps; Pseudomonas aeruginosa

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; PROTEIN PARC;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; GENE EXPRESSION; GENE MUTATION; HUMAN; LOWER RESPIRATORY TRACT INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

EID: 33846329834     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200701010-00013     Document Type: Article

References (10)

1. Obritsch MD, Fish DN, MacLaren R, Jung R. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 2005; 25: 1353-1364.
2. Hancock RE. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative Gram-negative bacteria. Clin Infect Dis 1998; 27 Suppi 1: S93-99.
3. Li Y, Mima T, Komori Y, Morita Y, Kuroda T, Mizushima T, et al. A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa. J Antimicrob Chemother 2003; 52: 572-575.
4. The ATS Board of Directors and the IDSA Guideline Committee. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416.
5. Li XR, Jia WX, Yang C, Liu L, Zeng W, Yang Y, et al. Study of type topoisomerase II mutation in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa. Clin J Antibiotic (Chin) 2003; 28: 155-159.
6. Xiong W, Sun ZY, Shen ZY. Drug resistance of Pseudomonas aeruginosa and mechanisms of its resistance to fluoroquinolones. Chin J Nosocomiol (Chin) 2003; 13: 204-206.
7. Peterson VM, Adamovicz JJ, Elliott TB, Moore MM, Madonna GS, Jackson WE 3rd, et al. Gene expression of hematoregulatory cytokines is elevated endogenously after sublethal gamma irradiation and is differentially enhanced by therapeutic administration of biologic response modifiers. J Immunol 1994; 153:2321-2330.
8. Zhao Q, Li XZ, Srikumar R, Poole K. Contribution of outer membrane protein OprM to antibiotic resistance in Pseudomonas aeruginosa independent of MexAB. Antimicrob Agents Chemother 1998; 42: 1682-1688.
9. Nakajima A, Sugimoto Y, Yoneyama H, Nakae T. High-level fluoroquinolone resistance in Pseudomonas aeruginosa due to interplay of the MexAB-OprM efflux pump and the DNA gyrase mutation. Microbiol Immunol 2002; 46: 391-395.
10. Jalal S, Ciofu O, Hoiby N, Gotoh N, Wretlind B. Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis. Antimicrob Agents Chemother 2000; 44: 710-712.